This report aims to provide detailed insights
into the global EMEA 3D
CBCT Market. It provides valuable information on the
type, procedure, application, and region in the market. Furthermore, the
information for these segments, by region, is also presented in this report.
Leading players in the market are profiled to study their product offerings and
understand the strategies undertaken by them to be competitive in this market.
Revenue Growth Analysis:
[115 Pages Report] The EMEA 3D
CBCT market is valued at 178.4 Million in 2017 and is expected to grow at a
CAGR of 9.0%
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=148086734
Key Factors Driving Market Growth:
The growing number of dentists
is one of the major drivers for the growth of the dental CBCT market in this
region. This increase, along with the subsequent establishment of new clinics
and rising government spending on healthcare, has contributed to a growing
demand for dental equipment like CBCT systems.
The dental segment accounted for the largest share of the EMEA 3D CBCT Market
On the basis of application,
the market is broadly segmented into dental and non-dental applications. The
dental applications segment further sub segmented into implantology, oral and
maxillofacial surgery, orthodontics, endodontics, and other dental
applications. The non-dental applications segment is sub segmented into ENT and
radiology. The dental application segment accounted for the largest share of
market in 2017. Large geriatric population in the European countries,
technological enhancements, wide adoption of 3D CBCT systems in dental implant
procedures, and the growing focus on the evaluation of post-treatment cases are
factors attributed to the large share of dental application.
ENT segment accounted for the largest share of the non-dental application
market
Based on the type, the
non-dental application EMEA 3D CBCT Market is further segmented into ENT and
radiology. In 2017, ENT segment accounted for the largest share of this market.
This dominant share is attributed to the increasing use of CBT imaging in the
diagnosis of ENT disorders due to advantages such as high spatial resolution,
better visibility of small details, lower radiation exposure compared to
traditional CT, patient convenience during examination, and compatibility of
CBCT systems with surgical navigation/image-guided surgery systems during ear
surgeries.
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=148086734
Europe dominated the
market:
Europe accounted
for the largest share of the EMEA 3D CBCT Market in 2017, followed by the Middle East and Africa.
The largest share of the European region is mainly attributed to the rising
geriatric population, increasing awareness about oral healthcare, rising
incidence of dental diseases, growing demand for advanced cosmetic dental
procedures, growing dental tourism in some European countries, and the
increasing number of dental clinics and hospitals in the region.
Even though the market is expected
to grow at a high CAGR, the high cost of 3D CBCT system in addition to the lack
of favorable reimbursement, is negatively impacting the adoption of new and
advanced technologies in the EMEA 3D
CBCT Market.
Key Players:
The key players in the EMEA 3D CBCT Market are Danaher
Corporation (US), DENTSPLY SIRONA (US), Carestream Dental (US), Planmeca Group
(Finland), VATECH (South
Korea), CEFLA (Italy), J. MORITA
CORPORATION (Japan), ACTEON GROUP (France), Asahi Roentgen (Japan),
and Genoray (South Korea).